AGBA GROUP HOLDING LTD (AGBA)

VGG012121023 - Common Stock

1.4  +0.18 (+14.75%)

After market: 1.39 -0.01 (-0.71%)

Fundamental Rating

1

AGBA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 99 industry peers in the Financial Services industry. AGBA may be in some trouble as it scores bad on both profitability and health. AGBA is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year AGBA has reported negative net income.
In the past year AGBA has reported a negative cash flow from operations.
In multiple years AGBA reported negative net income over the last 5 years.
In the past 5 years AGBA reported 4 times negative operating cash flow.

1.2 Ratios

AGBA has a Return On Assets of -51.50%. This is amonst the worse of the industry: AGBA underperforms 94.06% of its industry peers.
Industry RankSector Rank
ROA -51.5%
ROE N/A
ROIC N/A
ROA(3y)-13.05%
ROA(5y)-9.58%
ROE(3y)-503.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AGBA has a Gross Margin (37.97%) which is comparable to the rest of the industry.
AGBA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AGBA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.38%
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

AGBA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AGBA has more shares outstanding
The number of shares outstanding for AGBA has been increased compared to 5 years ago.
Compared to 1 year ago, AGBA has a worse debt to assets ratio.

2.2 Solvency

AGBA has an Altman-Z score of -0.99. This is a bad value and indicates that AGBA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.99, AGBA is not doing good in the industry: 74.26% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.99
ROIC/WACCN/A
WACC8.89%

2.3 Liquidity

AGBA has a Current Ratio of 0.59. This is a bad value and indicates that AGBA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.59, AGBA is doing worse than 64.36% of the companies in the same industry.
AGBA has a Quick Ratio of 0.59. This is a bad value and indicates that AGBA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.59, AGBA is doing worse than 64.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.75% over the past year.
AGBA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.61%.
The Revenue has been growing by 56.82% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)37.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.59%
Revenue 1Y (TTM)-35.61%
Revenue growth 3Y56.82%
Revenue growth 5YN/A
Sales Q2Q%-71.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AGBA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AGBA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AGBA GROUP HOLDING LTD

NASDAQ:AGBA (10/15/2024, 8:13:02 PM)

After market: 1.39 -0.01 (-0.71%)

1.4

+0.18 (+14.75%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-09 2024-08-09/amc
Earnings (Next)N/A N/A
Inst Owners0.04%
Inst Owner Change-65.26%
Ins Owners30.15%
Ins Owner Change0%
Market Cap264.98M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.91
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.2
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.5%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.97%
FCFM N/A
ROA(3y)-13.05%
ROA(5y)-9.58%
ROE(3y)-503.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.38%
GM growth 5YN/A
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z -0.99
F-Score5
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)96.28%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.1%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.59%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.61%
Revenue growth 3Y56.82%
Revenue growth 5YN/A
Sales Q2Q%-71.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1415.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1414.68%
OCF growth 3YN/A
OCF growth 5YN/A